Korean J Hematol.  2010 Sep;45(3):211-212. 10.5045/kjh.2010.45.3.211.

High-dose chemotherapy with reduced-dose craniospinal radiotherapy in children with newly diagnosed high-risk brain tumor

• Chung NG

• KMID: 2252067
• DOI: http://doi.org/10.5045/kjh.2010.45.3.211

Abstract

No abstract available.

MeSH Terms

Brain
Brain Neoplasms
Child
Humans

Reference

1. Kim SY, Sung KW, Hah JO, et al. Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor. Korean J Hematol. 2010; 45:120–126.

2. von Hoff K, Hinkes B, Gerber NU, et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer. 2009; 45:1209–1217. PMID: 19250820.

3. Chintagumpala M, Hassall T, Palmer S, et al. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol. 2009; 11:33–40. PMID: 18796696.

4. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006; 7:813–820. PMID: 17012043.

5. Pizer B, Clifford S. Medulloblastoma: new insights into biology and treatment. Arch Dis Child Educ Pract Ed. 2008; 93:137–144. PMID: 18809691.